Compare Natera Inc. Common Stock (NTRA) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs TotalEnergies SE — how do they compare? Natera Inc. Common Stock trades at $391.06 (market cap $57.03B), while TotalEnergies SE trades at $90.85 (market cap $197.99B). The key difference: TotalEnergies SE is far larger — about 3.5× Natera Inc. Common Stock's market cap, and TotalEnergies SE pays a 4.73% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and TotalEnergies SE for 91 Days on average.
| NTRA | TTE | |
|---|---|---|
Market Cap | $57.03B | $197.99B |
Volume | 1,131,157 | 2,678,834 |
Sector | Health | Energy |
52-Week High | $425.64 | $93.60 |
52-Week Low | $179.42 | $60.44 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $56.18B | $228.98B |
Dividend Yield | — | 4.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
TotalEnergies (TTE) trades at $88.95, up 0.66% on the day, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q1 and Q2 2026, while revenue and net income are projected to rebound in 2026. The company maintains solid profitability with a 9.08% net margin and a low P/E of 11.22, alongside a $10 billion investment plan in Argentina and increased share buybacks.
The outlook is positive, driven by strategic expansions in LNG and power, dividend growth targets, and favorable valuation. Key risks include exposure to oil price volatility and execution of capital-intensive projects. Wall Street consensus is bullish with a $95.33 price target, suggesting moderate upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
